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Background. Pseudotumor cerebri is an acknowledged but unusual complication of oral minocycline use. Vision loss and
papilledema have been described as mild and transient, and some authors suggest that treatment is not needed. Methods.C a s e
series of 2 patients with severe papilledema and visual ﬁeld loss. Results. Severe pseudotumor cerebri developed in 2 nonobese
patients taking minocycline. Their disease required further treatment even upon drug discontinuation because of visual ﬁeld loss
and papilledema. Conclusions. Minocycline-associated pseudotumor cerebri is not always a self-limited condition and may require
aggressive medical or surgical management.
Copyright © 2009 Simon R. Bababeygy et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
The pathogenesis of pseudotumor cerebri syndrome (PTC)
is poorly understood, although its diagnostic criteria are
well established [1]. While most cases are idiopathic, recent
data indicate that patients with severe forms of PTC may
have partial venous outﬂow obstruction [2–4], and such
patients may have greater long-term morbidity. Antibiotic
medications such as minocycline, tetracycline, and doxycy-
cline have also been repeatedly implicated as a causative
or contributory factor in PTC [5–7]. The prognosis of
minocycline-related PTC reported in the literature is quite
variable. Some authors suggest it is a benign condition that
resolves spontaneously upon discontinuing the antibiotic
[8, 9], while others report permanent vision loss may
ensue [5]. It is possible that venous sinus thrombosis was
a confounding factor regarding disease severity in some
instances, as most reported cases predate reliable mag-
netic resonance venography (MRV). Here we describe two
cases of minocycline-induced PTC with severe papilledema
and normal MRV, indicating that minocycline alone may
be associated with severe PTC without venous sinus
anomalies.
2.MaterialsandMethods
Retrospective case analysis was performed on cases of
pseudotumor cerebri seen by two of the authors (Michael
X. Repka, Prem S. Subramanian) in their clinical practices.
A speciﬁc search for nonobese patients (BMI ≤ 25) with
minocycline use at the time of pseudotumor cerebri diagno-
sis was made, and cases identiﬁed are presented below. IRB
approval was not required for this study by our institutional
guidelines, since it involves a case series of fewer than 3
patients.
3. Results
3.1. Case 1. A 23-year-old woman with a 4-month history
of doxycycline treatment and a subsequent 3-month his-
tory of minocycline treatment for acne developed tinnitus,
vomiting, phonophobia, and photophobia along with severe
headachesandprogressivehorizontalbinoculardiplopia.She
was otherwise healthy and took no other medications. Visual
acuity was 20/15 in the right eye and 20/20 in the left eye
withaleftrelativeaﬀerent pupillary defect. Humphrey visual
ﬁelds revealed a triangular scotoma in her left eye (Figure 1).2 Journal of Ophthalmology
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Figure 1: Automated perimetry results, case 1. In the left eye (a), the mean deviation was −4.02 with blind spot enlargement as well as some
depression extending toward ﬁxation from the blind spot. In the right eye (b), there was a mean deviation of −1.53 and slight enlargement
of the blind spot.4 Journal of Ophthalmology
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Figure 2: Optic disc appearance, case 2. Fundoscopy of the left eye (a) and right eye (b) reveals grade IV papilledema as evidenced by severe
elevation and hemorrhages.
Severe bilateral papilledema was present, greater on
the left than the right. Lumbar puncture demonstrated an
opening pressure of 41cm H2O with normal cerebrospinal
ﬂuid. Minocycline use was discontinued. Head CT and
contrast-enhanced MRI were both normal and an MRV
showed no venous thrombosis or stasis. The patient’s symp-
toms of diplopia improved 3 weeks later, but papilledema
and headache persisted with worsening of visual ﬁelds.
RepeatMRVwasnormal.Theintracranialpressureremained
elevated at 33cm H2O despite treatment with 2g aceta-
zolamide/day. Ventriculoperitoneal shunting was performed
for intracranial pressure control.
3.2. Case 2. A 15-year-old girl with a 6-week history of
minocycline treatment for acne vulgaris developed progres-
sive bifrontal headache with pain around the right eye,
vertical binocular diplopia, nausea, neck pain, and muscle
spasm. Visual acuity was 20/20-2 in the right eye and 20/15-
1 in the left eye. Threshold visual ﬁelds revealed enlarged
blind spots in both eyes, but otherwise normal ﬁndings.
Dilated ophthalmoscopy disclosed ﬂorid papilledema in
both eyes with peripapillary hemorrhages and choroidal
folds (Figure 2). Head CT and enhanced MRI were both
normal, and an MRV showed no evidence of venous throm-
bosis. The opening pressure was 55cm H2Ow i t hn o r m a l
CSF formula. Minocycline was discontinued. Acetazolamide
treatment was prescribed, then discontinued 5 months later
after resolution of the papilledema, headaches, visual ﬁeld
defects, and diplopia.
4. Discussion
We present 2 cases of minocycline-associated PTC in
nonobese patients in whom symptoms were severe, though
there were no signs of venous sinus thrombosis on MRV.
In one case, papilledema and elevated ICP persisted for
more than 3 months despite stopping minocycline. Vision
loss ensued in one patient despite maximal medical therapy.
Duration of PTC can never be known for sure, and it
is possible that both patients had disc swelling for some
time before diagnosis and thus suﬀered vision loss as a
result. However, vision loss and papilledema in PTC found
incidentally are usually mild. There is conﬂicting evidence
in the literature regarding the prognosis of minocycline-
induced PTC. In the largest published series of minocycline-
treated patients, consisting of 12 patients, 6 had severe
papilledema at diagnosis and 3 had residual visual ﬁeld
loss [5]. Kesler et al. reported 18 patients with a history of
tetracycline use associated with pseudotumor cerebri and
foundthat6patientshadarelapsingcourse,while12patients
had rapid recovery from the disease upon stopping the
antibiotic agent [10]. The authors suggested that tetracycline
played only a minor role in the patients who relapsed;
however, a number of their patients were obese [10], in
contrast to the patients we present in this report.
Others have stated that minocycline-induced PTC usu-
ally has minimal visual consequence and resolves rapidly
upon discontinuing the medication [8]. Normalization of
intracranial pressure within 1 month of stopping tetracycline
has been reported as well [9]. However, the mechanism by
which tetracycline or minocycline may induce pseudotumor
cerebri has not been determined. Our patient in case 1
was treated with both doxycycline and then minocycline,
although her symptoms did not arise until the latter drug
was used. Our ﬁndings suggest that minocycline alone may
induce severe PTC with persistently elevated intracranial
pressure, and patients with this condition may require
medical and surgical treatment beyond discontinuation of
the medication. We propose that minocycline-associated
pseudotumor cerebri is not a benign condition and must
be followed closely with aggressive interventions to prevent
vision loss.
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